Effect of Sex on Clinical Outcomes in Patients with Coronavirus Disease: A Population-Based Study

Kyu Hyang Cho1, Sang Won Kim2, Jong Won Park1

  • 1Division of Nephrology, Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu 705-717, Korea.

Insights

Female patients with coronavirus disease (COVID-19) experienced better clinical outcomes and survival rates compared to males. This sex-based difference in COVID-19 outcomes was particularly pronounced in older adult populations.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease (COVID-19) has presented unique challenges in understanding disease progression and patient outcomes.
  • Investigating demographic factors, such as sex, is crucial for a comprehensive understanding of COVID-19's impact.

Purpose of the Study:

  • To evaluate the association between patient sex and clinical outcomes in a large cohort diagnosed with COVID-19.
  • To identify potential sex-based disparities in COVID-19 severity and mortality.

Main Methods:

  • Retrospective analysis of a population-based dataset utilizing insurance claims data from Korea.
  • Inclusion of patients who tested positive for COVID-19, with diseases defined by the International Classification of Diseases 10th revision.
  • Assessment of clinical outcomes including mortality, hospitalization, and specific critical events using electrical codes.

Main Results:

  • A total of 7327 patients were analyzed: 40.5% male and 59.5% female.
  • Men exhibited higher incidence rates of mortality and adverse clinical outcomes compared to women.
  • Women demonstrated more favorable survival and clinical outcomes, especially in older age groups (50-64 and ≥65 years) and those with diabetes or hypertension.

Conclusions:

  • Female patients with COVID-19 generally experienced more favorable clinical outcomes.
  • The influence of sex on COVID-19 outcomes was more pronounced in elderly individuals (aged 50-64 or ≥65 years).
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
990
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
618
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
62
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
167